ST吉药(300108) - 2017 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was ¥191,671,075.82, down 8.31% compared to the same period last year[9]. - Net profit attributable to shareholders of the listed company was ¥26,337,996.03, a decrease of 42.51% year-on-year[9]. - Net profit attributable to shareholders after deducting non-recurring gains and losses was ¥22,276,516.03, down 50.40% compared to the previous year[9]. - Basic earnings per share for the reporting period were ¥0.0414, a decline of 42.50% year-on-year[9]. - The weighted average return on net assets was 1.42%, a decrease of 1.35% compared to the same period last year[9]. - Total operating revenue for the current period is ¥191,671,075.82, a decrease of 8.5% from ¥209,042,402.51 in the previous period[48]. - Net profit for the current period is ¥26,830,780.89, down 42.7% from ¥46,810,815.28 in the previous period[49]. - The company reported a total profit of ¥33,589,070.64, down 43.2% from ¥59,092,892.93 in the previous period[49]. - The company's total comprehensive income for the current period is ¥26,830,780.89, down from ¥46,810,815.28 in the previous period[51]. - The company's net profit for Q3 2017 was CNY 102,532,640.67, a decrease of 5.4% compared to CNY 109,011,725.19 in the same period last year[58]. - Operating revenue for Q3 2017 was CNY 80,831,280.52, down from CNY 84,493,795.89 in the previous year, representing a decline of 7.9%[61]. - The total profit for Q3 2017 was CNY 127,959,067.18, slightly lower than CNY 135,584,906.89 in Q3 2016, a decrease of 5.4%[58]. - The company's basic earnings per share for Q3 2017 was CNY 0.1582, down from CNY 0.1680 in the same quarter last year, reflecting a decline of 10.7%[59]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥2,747,369,819.17, an increase of 7.54% compared to the end of the previous year[9]. - Total liabilities at the end of the reporting period were RMB 869,469,482.37, compared to RMB 748,957,733.12 at the beginning, marking an increase of approximately 16.06%[39]. - The company's long-term borrowings increased to RMB 648,000,000.00 from RMB 584,000,000.00, reflecting a rise of about 10.95%[39]. - Current assets totaled RMB 1,195,796,566.99, up from RMB 1,008,382,517.29 at the start of the period, reflecting a growth of approximately 18.56%[36]. - The total equity attributable to shareholders of the parent company was RMB 1,850,705,266.69, up from RMB 1,780,545,476.15, an increase of approximately 3.36%[41]. - The total assets amount to ¥1,488,731,656.00, reflecting a slight decrease from ¥1,495,953,025.55 in the previous period[46]. Cash Flow - Cash flow from operating activities for the year-to-date was ¥62,939,193.54, an increase of 141.74% compared to the previous year[9]. - Cash flow from operating activities for Q3 2017 was CNY 62,939,193.54, a significant improvement compared to a negative cash flow of CNY -150,773,911.00 in the previous year[68]. - Operating cash inflow for the current period was 91,038,061.18, an increase from 83,730,910.84 in the previous period, representing a growth of approximately 1.56%[74]. - Net cash flow from operating activities was -3,059,589.64, a decline compared to 10,736,009.92 in the previous period[74]. - Investment activities generated a net cash flow of 18,643,751.63, a significant improvement from -3,033,422.73 in the previous period[74]. - Cash inflow from financing activities totaled 50,000,000.00, while cash outflow was 31,256,785.30, resulting in a net cash flow of -31,256,785.30[76]. - The ending balance of cash and cash equivalents was 4,847,127.93, down from 36,246,786.81 in the previous period, indicating a decrease of approximately 86.7%[76]. - Total cash and cash equivalents decreased by 15,672,623.31 during the period, contrasting with an increase of 23,581,267.05 in the previous period[76]. - Cash flow from sales of goods and services was 86,506,807.40, compared to 82,581,824.70 in the previous period, reflecting a growth of approximately 4.0%[72]. Expenses - Total operating costs increased to ¥163,030,317.29, up 7.9% from ¥151,048,908.71 in the previous period[48]. - Sales expenses surged by 163.27% to RMB 26,159,097.03 compared to the same period last year, mainly due to increased marketing expenses by a subsidiary[25]. - Financial expenses increased by 105.63% to RMB 24,855,292.40 compared to the same period last year, due to interest from specialized borrowings for a completed production base project no longer being capitalized[25]. - Management expenses rose to CNY 37,088,564.68 in Q3 2017, up from CNY 28,437,439.38 in the previous year, an increase of 30.5%[58]. - Financial expenses for Q3 2017 were CNY 24,885,292.40, compared to CNY 12,101,753.41 in the same period last year, indicating a rise of 105.5%[58]. Shareholder Information - The total number of shareholders at the end of the reporting period was 15,239, with the top ten shareholders holding significant stakes[14]. - The company distributed a cash dividend of RMB 0.5 per 10 shares, totaling RMB 31,800,733.70, approved at the 2016 annual shareholders' meeting[30]. - The company reported no non-operating fund occupation by controlling shareholders or related parties during the reporting period[32]. Future Outlook - The company plans to focus on expanding its market presence and investing in new product development to drive future growth[60].